2024-02-15 06:02:11 ET
- Aurinia Pharma press release ( NASDAQ: AUPH ): Q4 GAAP EPS of -$0.19 misses by $0.03 .
- Revenue of $45.1M (+58.8% Y/Y) misses by $0.06M .
- Shares -3.6% PM.
-
- $350.7 million of cash, cash equivalents, restricted cash and investments as of December 31, 2023
- Reaffirms 2024 net product revenue guidance of $200 - $220 million
- Announces conclusion of strategic review and details operational changes that are expected to drive savings of approximately $50 - $55 million annually
Read the full article on Seeking Alpha
For further details see:
Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M